Lysimachia Capillipes Capilliposide Inhibits AKT Activation and Restores Sensitivity to Gefitinib in NSCLC with Acquired Gefitinib Resistance

被引：0
|
作者：
Zhang, Shirong [1 ]
Xu, Yasi [1 ]
Jin, Er [2 ]
Zhu, Lucheng [3 ]
Xia, Bing [4 ]
Chen, Xufeng
Ma, Shenglin [5 ,6 ]
机构：
[1] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Ctr Translat Med, Nanjing, Jiangsu, Peoples R China
[2] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Resp Med, Hangzhou, Zhejiang, Peoples R China
[3] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Radiat Oncol, Nanjing, Jiangsu, Peoples R China
[4] Hangzhou Canc Hosp, Dept Radiat Oncol, Hangzhou, Zhejiang, Peoples R China
[5] Univ Calif Los Angeles, Los Angeles, CA USA
[6] Nanjing Med Univ, Hangzhou Peoples Hosp 1, Dept Oncol, Hangzhou, Zhejiang, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
Lysimachia capillipes Capilliposide; non-small cell lung cancer; Gefitinib resistance; AKT;
D O I：
10.1016/j.jtho.2016.11.1791
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.02b-123
引用
收藏
页码：S1268 / S1269
页数：2
相关论文
共 50 条
  • [21] miR-762 activation confers acquired resistance to gefitinib in non-small cell lung cancer
    Peng Ge
    Lei Cao
    Xin Chen
    Ruijun Jing
    Wanxia Yue
    BMC Cancer, 19
  • [22] RBM5 overexpression reverses acquired resistance to gefitinib in PC9/AB2 NSCLC cells
    Zhang, Jie
    Lv, Xuejiao
    Hao, Yuqiu
    Wang, Qi
    Meng, Guangping
    Zhang, Lin
    Su, Zhenzhong
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48
  • [23] Knockout of lncRNA UCA1 inhibits drug resistance to gefitinib via targeting STAT3 signaling in NSCLC
    Zhang, Biyuan
    Wang, Haiji
    Wang, Qi
    Xu, Jinpeng
    Jiang, Peng
    Li, Wei
    MINERVA MEDICA, 2019, 110 (03) : 273 - 275
  • [24] MicroRNA-214 Regulates the Acquired Resistance to Gefitinib via the PTEN/AKT Pathway in EGFR-mutant Cell Lines
    Wang, Yong-Sheng
    Wang, Yin-Hua
    Xia, Hong-Ping
    Zhou, Song-Wen
    Schmid-Bindert, Gerald
    Zhou, Cai-Cun
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2012, 13 (01) : 255 - 260
  • [25] Enhancement of sensitivity to tumor necrosis factor α in non-small cell lung cancer cells with acquired resistance to gefitinib
    Ando, K
    Ohmori, T
    Inoue, F
    Kadofuku, T
    Hosaka, T
    Ishida, H
    Shirai, T
    Okuda, K
    Hirose, T
    Horichi, N
    Nishio, K
    Saijo, N
    Adachi, M
    Kuroki, A
    CLINICAL CANCER RESEARCH, 2005, 11 (24) : 8872 - 8879
  • [26] Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling
    Nicola Normanno
    Manuela Campiglio
    Monica R. Maiello
    Antonella De Luca
    Mario Mancino
    Marianna Gallo
    Amelia D’Alessio
    Sylvie Menard
    Breast Cancer Research and Treatment, 2008, 112 : 25 - 33
  • [27] Breast cancer cells with acquired resistance to the EGFR tyrosine kinase inhibitor gefitinib show persistent activation of MAPK signaling
    Normanno, Nicola
    Campiglio, Manuela
    Maiello, Monica R.
    De Luca, Antonella
    Mancino, Mario
    Gallo, Marianna
    D'Alessio, Amelia
    Menard, Sylvie
    BREAST CANCER RESEARCH AND TREATMENT, 2008, 112 (01) : 25 - 33
  • [28] Gefitinib sensitivity in head and neck cancer cell lines is mediated by effects of the agent on downstream AKT and STAT3 activation
    Pierce, Carolyn
    Grushko, Tatyana A.
    Bacon, Michelle C.
    Olopad, Olufunmilayo I.
    Cohen, Ezra Ew
    CANCER RESEARCH, 2006, 66 (08)
  • [29] Gefitinib inhibits the growth and invasion of urothelial carcinoma cell lines in which Akt and MAPK activation is dependent on constitutive epidermal growth factor receptor activation
    Nicolle, G
    Daher, A
    Maillé, P
    Vermey, M
    Loric, S
    Bakkar, A
    Wallerand, H
    Vordos, D
    Vacherot, F
    de Medina, SGD
    Abbou, CC
    Van der Kwast, T
    Thiery, JP
    Radvanyi, F
    Chopin, DK
    CLINICAL CANCER RESEARCH, 2006, 12 (09) : 2937 - 2943
  • [30] Phenformin inhibits proliferation of acquired gefitinib resistant non-small-cell lung cancer(NSCLC) through the reduction of NAD+/NADH ratio
    Kim, Suntae
    Kang, Keon Wook
    FASEB JOURNAL, 2018, 32 (01):
12345